SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018)

SELLAS Life Sciences (SLS) posted quarterly Receivables - Other of $500000.0 for Q3 2017, up 102.5% quarter-over-quarter from -$20.0 million in Q1 2016.

SELLAS Life Sciences (SLS) Receivables - Other (2012 - 2018) Analysis & Trends

SELLAS Life Sciences (SLS) has reported Receivables - Other for 4 consecutive years, with $500000.0 the latest figure, recorded in Q3 2017.

  • In Q3 2017, Receivables - Other changed N/A year-over-year to $500000.0; the TTM figure through Sep 2017 stood at $500000.0 (changed N/A YoY), while the FY2016 annual figure was -$21.7 million, down 200.0% from the prior year.
  • Receivables - Other climbed to $500000.0 in Q3 2017 per SLS's latest filing, from -$20.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $21.7 million in Q4 2015 and bottomed at -$20.0 million in Q1 2016.
  • Historically, Receivables - Other has averaged $733333.3 across 3 years, with a median of $500000.0 in 2017.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 SELLAS Life Sciences 2.32 Bn 2.18 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2018 6.60 Mn
Sep 30, 2018 6.60 Mn
Sep 30, 2017 500,000.00
Sep 30, 2017 500,000.00
Mar 31, 2016 -20.00 Mn
Mar 31, 2016 -20.00 Mn
Dec 31, 2015 21.70 Mn
Dec 31, 2015 21.70 Mn
Dec 31, 2012 250,000.00
Dec 31, 2012 250,000.00